Apollo Hospitals Enterprise (BOM:508869) ROCE %: 21.40% (As of Mar. 2026)


BOM:508869 Apollo Hospitals Enterprise Ltd BOM:508869
93 GF Score
Price ₹8,897.35
GF Value ₹8,735.73
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Apollo Hospitals Enterprise ROCE %?

Apollo Hospitals Enterprise BOM:508869 +2.30% 93 ROCE % is 21.40% as of Mar. 2026. GuruFocus rates BOM:508869 with a GF Score™ of 93/100 and a GF Value™ of ₹8,735.73 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Apollo Hospitals Enterprise's annualized ROCE % for the quarter that ended in Mar. 2026 was 21.40%.

Apollo Hospitals Enterprise  (BOM:508869) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Apollo Hospitals Enterprise ROCE % Related Terms

Apollo Hospitals Enterprise ROCE % Historical Data

* Premium members only.

The historical data trend for Apollo Hospitals Enterprise's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollo Hospitals Enterprise ROCE % Chart

Apollo Hospitals Enterprise Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.88 13.29 15.44 17.73 19.57

Apollo Hospitals Enterprise Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.68 17.19 18.25 18.49 21.40
BOM:508869
93GF Score
Apollo Hospitals Enterprise Ltd BOM:508869
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apollo Hospitals Enterprise ROCE % Calculation

Apollo Hospitals Enterprise's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=31105/( ( (206574 - 45789) + (221969 - 64813) )/ 2 )
=31105/( (160785+157156)/ 2 )
=31105/158970.5
=19.57 %

Apollo Hospitals Enterprise's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=33624/( ( (0 - 0) + (221969 - 64813) )/ 1 )
=33624/( ( 0 + 157156 )/ 1 )
=33624/157156
=21.40 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 21.40% mean?
Apollo Hospitals Enterprise (BOM:508869) has a ROCE % of 21.40% as of Mar. 2026.
Is Apollo Hospitals Enterprise's ROCE % too high?
Apollo Hospitals Enterprise's current ROCE % is 21.40%. The Healthcare Providers & Services industry median ROCE % is 6.41. Apollo Hospitals Enterprise's value of 21.40% is 233.9% above this industry median. Overall, Apollo Hospitals Enterprise has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apollo Hospitals Enterprise's ROCE % compare to HCA and THC?
Apollo Hospitals Enterprise's ROCE % of 21.40% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Apollo Hospitals Enterprise's value of 21.40% is 233.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 643 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apollo Hospitals Enterprise's current ROCE % of 21.40% is 233.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apollo Hospitals Enterprise's current ROCE % is 21.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollo Hospitals Enterprise stock overvalued right now?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise (BOM:508869) is currently considered Fairly Valued. The stock's GF Value™ is ₹8,735.73, compared to a current price of ₹8,897.35 — trading 1.9% above its estimated fair value. The current ROCE % is 21.40% and 233.9% above the Healthcare Providers & Services industry median of 6.41. Apollo Hospitals Enterprise's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Apollo Hospitals Enterprise (BOM:508869), the current ROCE % is 21.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apollo Hospitals Enterprise (BOM:508869) Overvalued in 2026?

Based on GuruFocus' analysis, Apollo Hospitals Enterprise stock appears to be overvalued. The current stock price of ₹8,897.35 is trading 1.9% above its estimated GF Value™ of ₹8,735.73. GuruFocus considers Apollo Hospitals Enterprise to be Fairly Valued.

Key valuation signals for BOM:508869:

  • ROCE %: 21.40%
  • GF Value™: ₹8,735.73 vs. price of ₹8,897.35 (1.9% above fair value)
  • GF Score™: 93/100 with 4 warning signs
  • Industry Position: 233.9% above the Healthcare Providers & Services median

No single metric tells the full story. See the BOM:508869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Apollo Hospitals Enterprise Business Description

Other Exchanges APOLLOHOSP:India
Address No. 8-17, Shafee Mohammed Road, Sunny Side Building, East Block, 3rd Floor, Chennai, TN, IND, 600006
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
93GF Score

Get the complete analysis for BOM:508869

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8,897.35
Price
₹8,735.73
GF Value